Article Details

Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing

Retrieved on: 2019-02-12 08:00:00

Tags for this article:

Click the tags to see associated articles and topics

Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing. View article details on hiswai:

Excerpt

<div>Limited and existing investors <b>New Enterprise Associates</b>, Inc. (NEA) and Kleiner Perkins (KP). All investors have committed to fund an additional ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up